The FDA approved Pfizer's RSV vaccine for older adults 60 and older.

This will be the second approved RSV vaccine for older adults after GSK's.

Pfizer also has a maternal RSV vaccine to protect newborns that is expected to get FDA approval this summer.

The CDC's advisory committee will review the RSV vaccines this month, so we should have the RSV vaccines available before next fall.

Pfizer has trials for other ages, so expect to see the RSV vaccine available to all ages in the coming years.